Bictegravir / Emtricitabine / Tenofovir Alafenamide

Strength: 50 mg / 200 mg / 25 mg

Dosage Form: Tablet

Description:

This single-tablet regimen combines Bictegravir (an integrase inhibitor) with Emtricitabine and Tenofovir Alafenamide, offering potent antiviral activity with improved safety for kidney and bone health.

Key Features:

• Once-daily single tablet regimen
• High barrier to resistance
• Reduced renal and bone toxicity risk

Precautions:

• Not recommended for patients with severe renal impairment
• Regular monitoring advised
• Inform your doctor of all other medications